Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Look for a functional medicine or anti-aging practitioner with peptide therapy experience
The drug was first licensed for type 2 diabetes as it primarily affects blood sugar levels
The correct comparison is tirzepatide monotherapy versus retatrutide monotherapy, either in sequence or when enrolling in a retatrutide trial
The per patient cost savings were 8151, 5597 and 2456, with QALY gains of 0.624, 0.849 and 0.880 for tirzepatide 5, 10 and 15 mg versus liraglutide 3 mg, respectively
US$ 27.29
US$ 20.88
US$ 29.17
US$ 21.99
US$ 28.95
US$ 25.94
US$ 22.07
